Renalytix AI plc (RNLX)
Market Closed
7 Oct, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 21
+0.01
+5.66%
$
22.55M Market Cap
- P/E Ratio
0% Div Yield
726,332 Volume
-0.34 Eps
$ 0.2
Previous Close Day Range
0.19 0.23
Year Range
0.18 2.4
Want to track RNLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Renalytix reports £4m balance sheet boost as notes convert
Renalytix PLC (AIM:RENX) has announced a $4 million balance sheet improvement, following the conversion of senior convertible bonds into equity. Some 31.6 million new ordinary shares will be issued at 9.5p per share.
Proactiveinvestors | 2 months ago
Renalytix shares gain as billable test numbers set new company record
Renalytix PLC (AIM:RENX) shares moved up on Thursday thanks to an upbeat trading update, revealing a 20% rise in third-quarter revenue. The company, which specialises in artificial intelligence-enabled in vitro diagnostics, told investors it processed more than 1,000 billable kidneyintelX.dkd tests in the quarter.
Proactiveinvestors | 8 months ago
2025 © Marketlog. All Rights Reserved.
